Halozyme Therapeutics Inc (HALO)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 444,091 | 281,594 | 202,129 | 402,710 | 129,085 |
| Revenue | US$ in thousands | 1,015,320 | 829,253 | 660,116 | 443,310 | 267,594 |
| Net profit margin | 43.74% | 33.96% | 30.62% | 90.84% | 48.24% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $444,091K ÷ $1,015,320K
= 43.74%
Based on the provided data, Halozyme Therapeutics Inc's net profit margin has shown some fluctuations over the years. Starting at 48.24% on December 31, 2020, the margin significantly increased to 90.84% by December 31, 2021, reflecting a strong performance in generating profits relative to revenue.
However, in the following years, the net profit margin experienced a decline, dropping to 30.62% by December 31, 2022, and then increasing slightly to 33.96% by December 31, 2023. By December 31, 2024, the net profit margin improved to 43.74%, indicating a recovery in the company's profitability.
Overall, while there have been fluctuations in Halozyme Therapeutics Inc's net profit margin over the years, the company has demonstrated resilience and managed to maintain a healthy level of profitability, with an upward trend in recent years.
Peer comparison
Dec 31, 2024